NON-SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON-SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test guides new attack on lung cancer return
Disease control Recruiting nowThis study is for people with early-stage non-small cell lung cancer who have finished standard treatment. A blood test looks for tiny bits of cancer DNA (ctDNA) that might mean the cancer could come back. If the test is positive, participants get a drug called durvalumab to try …
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Cancer-Fighting virus shows promise in lung cancer trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease has worsened after initial treatment. Participants receive an experimental virus therapy (Olvi-Vec) followed by chemotherapy and an immunotherapy drug, or standard chemo alone. The goal is to see i…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Breathing new life: exercise program aims to ease shortness of breath in advanced lung cancer
Symptom relief Recruiting nowThis study tests whether an 8-week pulmonary rehabilitation program (exercise and breathing training) can improve shortness of breath, fatigue, and quality of life in people with advanced non-small cell lung cancer. Half of the 85 participants will receive rehab, while the other …
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC
-
New radiation technique aims to protect heart during cancer treatment
Knowledge-focused Recruiting nowThis study tests whether a newer, MRI-guided radiation method (MRgART) is gentler on the heart than standard radiation (LINAC) for people with lung, esophageal, or other chest cancers. About 60 adults will receive radiation and have their heart function checked with MRIs and bloo…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC